ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0628 • ACR Convergence 2021

    Higher Quality of Care for Patients with Systemic Lupus Erythematosus in a Subspecialty Lupus Clinic: A Multi-Setting Cross-Sectional Study

    Sidha Sreedharan1, Ning Li1, Geoffrey Littlejohn1, Russell Buchanan2, Mandana Nikpour3, Eric Morand4, Alberta Hoi5 and Vera Golder6, 1Monash University, Melbourne, Australia, 2Austin Health, Heidelberg, Melbourne, Australia, 3University of Melbourne at St Vincent's Hospital, Melbourne, Australia, 4School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 5Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia, 6Monash University, Clayton, Australia

    Background/Purpose: Healthcare quality for systemic lupus erythematosus (SLE) is a modifiable target for improving patient outcomes. Disease-specific subspecialty lupus clinics may offer experienced healthcare professionals,…
  • Abstract Number: 0629 • ACR Convergence 2021

    Patient and Physician Satisfaction with Telemedicine Utilization for Delivery of Care in Patients with SLE – A Single Centre Experience

    Tanmayee Bichile1, Amanda Bembic2, Susan Manzi1 and Sonia Manocha1, 1Allegheny Health Network, Pittsburgh, PA, 2Allgheny Health Network, Pittsburgh, PA

    Background/Purpose: COVID 19 has forced the healthcare system to utilize telemedicine to provide dependable and timely care for patients with SLE. Telemedicine has been used…
  • Abstract Number: 0630 • ACR Convergence 2021

    Telemedicine in Rheumatology Care: A Systematic Review

    Lesley Jackson1, Timothy Edgil2, Brittany Hill3, Catherine H. Smith4, Jasvinder Singh1 and Maria I. Danila1, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of General Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, 3Brookwood Baptist Health, Leeds, AL, 4Lister Hill Library of the Health Sciences, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Coronavirus disease 2019 (COVID-19) pandemic led to a dramatic uptake of telemedicine in rheumatology. Given the impact of the pandemic on care delivery, we…
  • Abstract Number: 0631 • ACR Convergence 2021

    Provider Assessment of Telehealth Utility During COVID-19

    Catherine Howe1, Isaac Smith1, Robert Overton2, Ricardo Henao2, Nicoleta Economou-Zavlanos2, Jayanth Doss3, Megan Clowse4 and David Leverenz3, 1Duke University Hospital, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University, Durham, NC, 4Duke University, Chapel Hill, NC

    Background/Purpose: The COVID-19 pandemic forced the provision of telehealth care to rheumatology patients with a broader range of diagnoses and disease activity than previously studied.…
  • Abstract Number: 0632 • ACR Convergence 2021

    Impact of COVID-19 and Telehealth on RAPID3 Screening in an Academic Rheumatology Practice: Identifying Disparities in Care

    Poorva Apte1, Robert Overton2, Ricardo Henao1, Nicoleta Economou-Zavlanos2, Jayanth Doss1, Megan Clowse3 and David Leverenz1, 1Duke University, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University, Chapel Hill, NC

    Background/Purpose: Measuring disease activity in patients with inflammatory arthritis is important for providing optimal treat-to-target care. The COVID-19 pandemic has widened disparities in care among…
  • Abstract Number: 0633 • ACR Convergence 2021

    Value of the Routine Assessment of Patient Index Data 3 (RAPID3) as a Disease Activity Measure in Patients with Psoriatic Arthritis

    Johny Fares1, Andrea Healy1 and Martin Bergman2, 1Main Line Health, Wynnewood, PA, 2Martin Jan Bergman, MD, Ridley Park, PA

    Background/Purpose: The RAPID3 is a patient-reported pooled index of three measures: function, pain, and patient global estimate of status, that is used to classify disease…
  • Abstract Number: 0634 • ACR Convergence 2021

    Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease

    Andrea Healy1, Johny Fares1, Martin Bergman2, Kaleb Michaud3, Alison Petro3 and Harlan Sayles3, 1Main Line Health, Wynnewood, PA, 2Martin Jan Bergman, MD, Ridley Park, PA, 3University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: There has been significant work developing questionnaires to find effective and reliable ways of characterizing the functional status of patients, to track disease progression…
  • Abstract Number: 0635 • ACR Convergence 2021

    Correlation Between Provider Documentation and Patient Experience with Contraceptive Counseling in an Academic Rheumatology Practice

    Guiset Carvajal Bedoya1, Tara Skorupa2, Kristin Sturm2, Ju Young Kwag2, Kristen Demoruelle3 and JoAnn Zell3, 1University of Colorado, aurora, CO, 2University of Colorado, Denver, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: In a prior survey of providers and patients (Chakravarty 2014), it became apparent that clear gaps exist in provider-patient communication, affecting the delivery and…
  • Abstract Number: 0636 • ACR Convergence 2021

    Contraceptive and Pre-conception Counseling in an Academic Rheumatology Practice: A Needs Assessment to Identify Gaps in Care

    Tara Skorupa1, Guiset Carvajal2, Kristin Sturm1, Ju Young Kwag3, JoAnn Zell1 and Kristen Demoruelle1, 1University of Colorado Anschutz Medical Campus, Aurora, CO, 2University of Colorado, Colorado, CO, 3University of Colorado, Denver, CO

    Background/Purpose: Systemic autoimmune conditions affect women of childbearing age, and teratogenic medications are commonly prescribed as treatment. In this study, we surveyed rheumatology patients to…
  • Abstract Number: 0637 • ACR Convergence 2021

    Assessing the Rates of Cervical Cancer Screening in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Tara Skorupa1, Sonia Khatter2, Alana Freifeld1 and Elena Weinstein3, 1University of Colorado, Denver, CO, 2University of Colorado, Aurora, CO, 3University of Colorado, Englewood, CO

    Background/Purpose: Prior studies have described increased incidence of cervical dysplasia and cervical cancer in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), suggesting…
  • Abstract Number: 0638 • ACR Convergence 2021

    Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps

    P. Daniel Nicholas1, Jonida Cote2, Dante Grassi1, Swana Thomas3, Joseph Chronowski1, David Pugliese4 and Eric Newman1, 1Geisinger Medical Center, Danville, PA, 2Geisinger Medical Center, Orefield, PA, 3Geisinger Medical Center, Wilkes-Barre, PA, 4Geisinger Medical Center, Wilkes Barre, PA

    Background/Purpose: The Centers for Disease Control and Prevention and expert rheumatologists recommend screening for HBV and HCV prior to DMARD initiation and the ACR recommends…
  • Abstract Number: 0639 • ACR Convergence 2021

    Improving Pre-biologic Infection Screening Using a Best Practice Alert in Electronic Health Records

    Hailey Baker1, Rebecca Fine1, Betty Hsiao2, Vaidehi Chowdhary3, Lisa Suter4 and Abhijeet Danve5, 1Yale University, New Haven, CT, 2Yale-New Haven Medical Center, New Haven, CT, 3Yale University, East Haven, CT, 4Yale School of Medicine, New Haven, CT, 5Yale University, Rocky Hill, CT

    Background/Purpose: Biologics and small molecules (bDMARDs) are important immunomodulatory medications for management of patients with rheumatic diseases. Use of a bDMARD in patients with infection…
  • Abstract Number: 0640 • ACR Convergence 2021

    Implementation of Digital Prompt in Electronic Medical Records Improves Pneumonia Vaccination Rates in Patients Prescribed TNF-Inhibitors

    Manjeet Bhamra1 and Andras Perl2, 1SUNY Upstate Medical University, Syracuse, NY, 2State University of New York, Syracuse, NY

    Background/Purpose: Tumor necrosis factor α inhibitors (TNFi) predispose to bacterial infections including pneumonia. In turn, vaccination with pneumococcal 13 valent (PCV13) and pneumococcal 23 valent…
  • Abstract Number: 0641 • ACR Convergence 2021

    Title: EHR-Supported Staff Protocol Improves Smoking Cessation in a Diverse Rheumatology Clinic: Updated Results of Quit Connect Dissemination

    Jennifer Brandt1, Edmond Ramly2, Monica Messina3, S Sam Lim4 and Christie Bartels3, 1Emory School of Medicine, Atlanta, GA, 2University of Wisconsin School of Medicine, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Smoking is a risk factor for rheumatologic conditions like lupus and rheumatoid arthritis and predicts worse outcomes. Smoking and rheumatic disease increase risk for…
  • Abstract Number: 0642 • ACR Convergence 2021

    Prevalence and Risk Factors for Cardio-metabolic Abnormalities in Patients with Inflammatory Arthritis Attending Cardio-rheumatology Primary Prevention Clinics

    Lihi Eder1, Shadi Akhtari2, Dana Jerome1, Jacob Udell1, Patrick Lawler1, Paula Harvey3 and Bindee Kuriya4, 1University of Toronto, Toronto, ON, Canada, 2Women's College Hospital, University of Toronto, North York, ON, Canada, 3Women's College Hospital, University of Toronto, Toronto, ON, Canada, 4University of Toronto - Toronto, Toronto, ON, Canada

    Background/Purpose: Cardio-metabolic abnormalities are common in patients with inflammatory arthritis (IA) but tend to be under-recognized and under-treated. We aimed to compare the prevalence and…
  • « Previous Page
  • 1
  • …
  • 745
  • 746
  • 747
  • 748
  • 749
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology